drugset / Trial / NCT00511563

A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

NCT00511563 ↗

Phase 2 Withdrawn GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

To better understand the way that GW876008 and GSK561679 work on hormone responses in patients with Irritable Bowel Syndrome.

Timeline

Start
2007-08
Primary completion
2012-11
Completion
—

Outcome

Outcome not reported

Stopped: “Cancelled before active due to the results of emerging scientific data”

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule — —
Subject VERUCERFONT Small molecule — —